Jul 21, 2020
UM researchers find new targets for deadly children’s brain tumour
After discovering how a specific gene fuels a deadly form of children’s brain tumour, University of Manitoba researchers have...
Jul 16, 2020
Finding hints at novel target for Ewing sarcoma therapy
New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature. Read more:...
Jul 13, 2020
Scientists discover way to stop spread of devastating childhood cancer
Researchers at the University of East Anglia and University of Manchester have made an important breakthrough that could lead to "kinder"...
Jul 10, 2020
Monitoring for breast cancer after childhood chest radiation: When and how?
Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more...
Jul 6, 2020
Rituximab Regimen Improves Survival in Children With Aggressive B-Cell Lymphoma
Adding rituximab (Rituxan, Truxima) to chemotherapy may be a new standard for treating children and young adults newly diagnosed with...
Jun 30, 2020
Readily Available MRI Technique Could Shed Light on Common Pediatric Cancer
T1 mapping has the potential to determine neuroblastoma aggressiveness, as well as early efficacy of treatment. Read more:...
Jun 26, 2020
Drug used in breast and ovarian cancer could lead to safer, more effective treatment for neuroblasto
A type of drug known as a PARP inhibitor, already used to treat breast and ovarian cancer, may be useful in treating children with...
Jun 23, 2020
Online tool helps doctors predict whether childhood cancer treatment will lead to premature menopaus
Risk calculator developed by U of A master’s student could help reduce long-term health consequences for girls who survive cancer. Read...
Jun 23, 2020
Targeting stem cells: The path to curing poor-prognosis leukaemia
Researchers at Children's Cancer Institute have discovered what could prove a new and improved way to treat the poor-prognosis blood...
Jun 8, 2020
Identifying survivors at high risk of secondary cancers
Scientists at St. Jude Children's Research Hospital are studying the combined effect of cancer treatments and inherited mutations in...